Jiujie Cui
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
- Oncology 32
- Pancreatic and Hepatic Oncology Research 20
- Cancer Immunotherapy and Biomarkers 4
-
- MicroRNA in disease regulation 4
- Co-authors
- Keping Xie (16 shared papers)Zhiliang Jia (10 shared papers)Yong Gao (9 shared papers)Ming Quan (15 shared papers)Dacheng Xie (9 shared papers)Daoyan Wei (6 shared papers)Liwei Wang (12 shared papers)Suyun Huang (6 shared papers)
- Journals
- Clinical Cancer Research (7 papers)Cancer Letters (4 papers)Oncotarget (3 papers)Current Pharmaceutical Design (3 papers)Frontiers in Cell and Developmental Biology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jiujie Cui
74 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 793
- Oncology 784
- Molecular Biology 1.6k
- Cell Biology 207
- Immunology 206
Countries citing papers authored by Jiujie Cui
This map shows the geographic impact of Jiujie Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiujie Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiujie Cui more than expected).
Fields of papers citing papers by Jiujie Cui
This network shows the impact of papers produced by Jiujie Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiujie Cui. The network helps show where Jiujie Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiujie Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 209 | |
| 2 | 2014 | 207 | |
| 3 | 2014 | 165 | |
| 4 | 2012 | 130 | |
| 5 | 2019 | 106 | |
| 6 | 2012 | 96 | |
| 7 | 2014 | 92 | |
| 8 | 2013 | 91 | |
| 9 | 2013 | 91 | |
| 10 | 2014 | 76 | |
| 11 | 2016 | 70 | |
| 12 | 2012 | 69 | |
| 13 | 2015 | 58 | |
| 14 | 2013 | 57 | |
| 15 | 2015 | 55 | |
| 16 | 2013 | 54 | |
| 17 | 2014 | 54 | |
| 18 | 2023 | 54 | |
| 19 | 2023 | 52 | |
| 20 | 2018 | 49 |
About Jiujie Cui
Jiujie Cui is a scholar working on Oncology, Cancer Research, Molecular Biology, Cell Biology and Pulmonary and Respiratory Medicine, having authored 77 papers that have together received 2.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (20 papers), FOXO transcription factor regulation (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Kruppel-like factors research (6 papers), Hippo pathway signaling and YAP/TAZ (5 papers), Ferroptosis and cancer prognosis (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (793 citations), Oncology (784 citations), Molecular Biology (1.6k citations), Cell Biology (207 citations) and Immunology (206 citations). Jiujie Cui has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Keping Xie, Zhiliang Jia, Yong Gao, Ming Quan, Dacheng Xie, Daoyan Wei, Liwei Wang, Suyun Huang, Min Xian Shi and Weihua Jiang. Their work appears in journals such as Clinical Cancer Research, Cancer Letters, Oncotarget, Current Pharmaceutical Design and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.